Veterinary Medicines

Cardisan 2.5 mg chewable tablets for dogs

Authorised
  • Pimobendan
Download as PDF

Product identification

Medicine name:
Cardisan 2.5 mg chewable tablets for dogs
Cardisan, 2,5 mg närimistabletid koertele
Active substance:
  • Pimobendan
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pimobendan
    2.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC01CE90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • Cardbox containing 12 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.
  • Cardbox containing 10 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.
  • Cardbox containing 9 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.
  • Cardbox containing 6 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.
  • Cardbox containing 3 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Lelypharma B.V.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1089722
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0380/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 22/11/2023
Download

Combined File of all Documents

English (PDF)
Published on: 28/12/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."